Analyzing...
Loading company...
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹880 Cr service revenue.
Employee costs at 18.5% of revenue — primary cost driver.
“achieved our highest ever EBITDA at rupees $742,000,000, up by 35% year over year.”
“revenue of rupees 3,205 million, reflecting a strong growth of 46% year over year and 15% growth quarter over quarter.”
“Quarter three FY 'twenty six marked yet another quarter of industry leading performance for Yataf Hospitals with a robust 46% Y o Y revenue growth trajectory”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 8.1%▲ | 7.9% |
| ROCE | 10.9%▼ | 11.3% |
| Net Margin | 14.6%▲ | 9.3% |
| EBITDA Margin | 26.4%▲ | 21.9% |
| Debt To Equity | 0.00x▼ | 0.16x |
| Employee Cost Ratio | 18.50x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | ₹1,089 Cr +23.7% | ₹880 Cr +31.3% | ₹671 Cr |
| Other Income | ₹32 Cr +97.6% | ₹16 Cr +3.6% | ₹16 Cr |
| Total Income | ₹1,121 Cr +25.1% | ₹897 Cr +30.7% | ₹686 Cr |
| COGS | ₹219 Cr +22.6% | ₹179 Cr +33.9% | ₹133 Cr |
| ₹902 Cr +24.5% | ₹725 Cr +37.0% | ₹529 Cr | |
| Profit Before Tax | ₹219 Cr +27.6% | ₹172 Cr +9.5% | ₹157 Cr |
| ₹54 Cr +31.2% | ₹41 Cr -2.8% | ₹42 Cr | |
| Net Profit | ₹165 Cr +26.5% | ₹131 Cr +14.0% | ₹114 Cr |
| Profit (Owners) | ₹167 Cr +28.2% | ₹131 Cr +14.0% | ₹114 Cr |
| Minority Interest | (₹2 Cr) | ₹0.00 Cr | ₹0.00 Cr |
| Other Comprehensive Income | ₹0.35 Cr +18.1% | ₹0.29 Cr +159.3% | ₹0.11 Cr |
| EPS | ₹17.37 | ₹13.55 | ₹13.33 |
| Diluted Shares | ₹10 Cr | ₹10 Cr | ₹9 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
We hereby submit intimation regarding Schedule of Investor Conference.
We hereby submit Earnings Call Transcript Q4 FY26.
We hereby submit Newspaper Publication of Financial Results - Q4 & FY26.
We hereby submit intimation regarding Schedule of Conference Call.
We hereby submit Press Release Q4 FY2026.
We hereby submit Audited Financial Results for Q4 & FY2026.
We hereby submit the Outcome of Postal Ballot of the Company held on May 12, 2026. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.
We hereby submit Press Release on Hospital Asset Acquisition in Sector 40 Gurugram.
We hereby submit intimation regarding Hospital Asset Acquisition in Sector 40 Gurugram.
Yatharth Hospital & Trauma Care Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
We hereby submit the intimation related to Personnel's authorized for determining Materiality of events/information.
We hereby submit Earnings Call Transcript Q3 FY26.
We hereby submit Monitoring Agency Report for the quarter ended December 31, 2025 - IPO.
We hereby submit Monitoring Agency Report for the quarter ended December 31, 2025 - QIP.
We hereby submit Earnings Call Recording- Q3 FY26.
No dividend history available for this company.